COMPASS Pathways PLC ADR (CMPS) News
Filter CMPS News Items
CMPS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CMPS News Highlights
- CMPS's 30 day story count now stands at 5.
- Over the past 14 days, the trend for CMPS's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about CMPS are DEC, RES and TR.
Latest CMPS News From Around the Web
Below are the latest news stories about COMPASS PATHWAYS PLC that investors may wish to consider to help them evaluate CMPS as an investment opportunity.
Compass Pathways announces investigational COMP360 psilocybin treatment was well-tolerated in phase 2 study of post-traumatic stress disorderInitial safety findings at 24 hours post dosing were consistent with studies of COMP360 in other psychiatric conditionsLONDON, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that an initial data readout showed that investigational COMP360 psilocybin treatment was well-tolerated in a phase 2 clinical trial of people living with post-tr |
25 Best Online Psychology Degree Programs Heading Into 2024In this article, we will be looking at the 25 best online psychology degree programs heading into 2024. If you want to skip our detailed analysis, you can go directly to the 5 Best Online Psychology Degree Programs Heading Into 2024. Global Mental Health Industry: An Overview According to a report by IMARC, the global mental health […] |
Compass Pathways appoints Teri Loxam as Chief Financial OfficerLONDON, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Teri Loxam as Chief Financial Officer (CFO), effective the beginning of March 2024. She will be based in the company’s New York City office. Teri will serve as an advisor during the period leading up to her appointment as CFO. Teri brings to Compass deep and |
Study results of psilocybin treatment in bipolar II depression published in JAMA PsychiatryBelieved to be first ever psilocybin clinical trial for treatment of bipolar II depressionLONDON, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of a paper inJAMA Psychiatry that demonstrates the potential for investigational COMP360 psilocybin treatment in treatment-resistant bipolar type II disorder (bipolar II). Res |
Investing in Mental Health: 3 Stocks in the Wellness SpaceMental health stocks can be a great addition to your portfolio as its importance becomes increasingly recognized. |
Compass Pathways to participate in upcoming Evercore investor conferenceLONDON, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference at 10:25 am ET on November 30, 2023. A live audio webcast of the fireside chat will be accessible from the “Events” page of the Investors section of the Compass website. The replay of the webcast wi |
GH Research Drags Down Psychedelic Drug Stocks Index By 7%The 5 constituents in the Psychedelic Drug Stocks Index continue to exhibit extreme volatility week after week. |
Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research centerUK sites to participate in part of pivotal phase 3 program following Medicines and Healthcare Regulatory Agency approval of study Research will take place in the UK, including at the newly opened Centre for Mental Health Research and Innovation in London, developed in partnership with South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology & Neuroscience at King’s College London LONDON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Com |
COMPASS Pathways plc (NASDAQ:CMPS) Q3 2023 Earnings Call TranscriptCOMPASS Pathways plc (NASDAQ:CMPS) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Good day, ladies and gentlemen, and welcome to the COMPASS Pathways Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. As a reminder, this call is being recorded. I would now like to introduce your host […] |
Compass Pathways Plc (CMPS) Q3 2023 Earnings Call TranscriptAgain, my name is Steve Schultz, senior vice president of investor relations at COMPASS Pathways. Today, I'm joined by Kabir Nath, our chief executive officer; Mary-Rose Hughes, our interim chief financial officer; and Dr. Guy Goodwin, our chief medical officer. |